As in all great stories, as one chapter ends, another begins; OriGen is proud to announce that Beth San Segundo will be transitioning to Chief Executive Officer. Beth has been at OriGen since its founding, having been hired on as employee number three. She previously served at the senior level of Sales and Marketing at OriGen Biomedical where she oversaw significant growth in new markets and guided the organization’s success. Beth has a deep understanding of customer needs and medical device manufacturing. Beth has an MBA from St. Edwards University and a BS in Biology from the University of Texas at Austin.
OriGen is in a period of significant growth both in the United States and globally. We look forward to continuing to work with our global partners and customers to continue to provide a positive impact to Cell Therapy and ECMO procedures.